Articles
I have just received an email from a representative of MAX BioPharma, a biotechnology company based in Santa Monica CA, which directed me to the company’s crowdfunding campaign for a hair loss experiment. After taking a quick review of the company and the campaign, I’ve decided it’s worthwhile to share here. About The Company MAX BioPharma…
Read MoreAfter I shared an update about a potential announcement time frame for Shiseido a few weeks ago, I read a few queries from readers who wondered if a Shiseido market release would be available to everyone in the world. Today, I received more positive news from a credible source to help clear things up. Once again,…
Read MoreTissue regeneration company PolarityTE has recently been featured in the media for positive results from its SkinTE product in a severe burn patient case. The company announced the news formally today via press release. To recap PolarityTE’s recent developments, the company has been rolling out its SkinTE product for skin/wound healing in select hospitals and…
Read MoreA research team from the University of Alabama at Birmingham have identified a gene in mice that can lead to skin wrinkles, gray hair, and hair loss….or the reversal of such disorders. Keshav Singh PhD and colleagues have discovered a genetic mutation affecting mitochondria to be a major regulator of health and the aging process.…
Read MoreMore news of progress is coming from Histogen and it’s going to raise a few eyebrows. This time, founder Gail Naughton gives details about the HSC660 trial in women and a late stage trial for men in Mexico. While browsing an article featuring Histogen on the San Diego Union Tribune website, I discovered some new…
Read MoreThings are heating up. Cassiopea SpA issued a press release today announcing “very positive” interim analysis phase 2 results for Breezula in the treatment of androgenic alopecia. Breezula is a topical anti-androgen and also known as Clascoterone. Here are some significant details I found while reading the release: The trial comprises 404 subjects and is…
Read MoreFollicle Thought has received a brief update to share regarding the progress of the highly anticipated company Shiseido. On July 4th I sent a tweet to Replicel CEO Lee Buckler asking him when he thought we would hear an announcement from Shiseido pertaining to their trial of RCH-01. His response is shown below. As you…
Read MoreI just received an email from Histogen that they have begun recruitment for their clinical trial of HSC660 in female pattern baldness. Full press release below. I know so many women are going to be happy reading this. 🙂 Histogen Press Release Histogen Kicks Off Clinical Trial for Female Hair Loss SAN DIEGO, July 2,…
Read MoreI’m pleased to share with you all a startup which is a little bit “outside the box” from the usual companies you’d see on Follicle Thought. Today’s topic of interest, Birch BioMed, is based in Vancouver, Canada and was birthed on the campus of the University of British Columbia. The company’s prize clinical candidate is…
Read MoreSCM Lifescience is a biotechnology company based in South Korea with a focus on adult stem cell therapeutics. The company had caught my eye several months ago when I read about its plans to develop a stem-cell derived product for hair growth. Since then, SCM seems to be making progress on that path. SCM Lifescience…
Read More